Mid-America GI Clinical Research ( Site 5130) — Kansas City, Missouri

Mid-America GI Clinical Research ( Site 5130) is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid-America GI Clinical Research ( Site 5130) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Crohn's Disease.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-America GI Clinical Research ( Site 5130)?

Mid-America GI Clinical Research ( Site 5130) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-America GI Clinical Research ( Site 5130) conducted?

Mid-America GI Clinical Research ( Site 5130) has 1 clinical trials on record, with 1 currently active. Their work covers Crohn's Disease.

Is Mid-America GI Clinical Research ( Site 5130) accredited by Crixeo Clinical Trials?

Mid-America GI Clinical Research ( Site 5130) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-America GI Clinical Research ( Site 5130)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.